Cargando…

CYP1A2 activity as a risk factor for bladder cancer.

CYP1A2, CYP2D6 and N-acetyltransferase activities were estimated in 100 patients with bladder cancer and 84 control subjects from measurements of theophylline, metoprolol and isoniazid and their metabolites in urine, respectively. The frequency of occurrence of slow acetylators of isoniazid and poor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, S. W., Jang, I. J., Shin, S. G., Lee, K. H., Yim, D. S., Kim, S. W., Oh, S. J., Lee, S. H.
Formato:	Texto
Lenguaje:	English
Publicado:	Korean Academy of Medical Sciences 1994
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3054229/ https://www.ncbi.nlm.nih.gov/pubmed/7786445

Ejemplares similares

Phase II study of S-1 combined with oxaliplatin as therapy for patients with metastatic biliary tract cancer: influence of the CYP2A6 polymorphism on pharmacokinetics and clinical activity
por: Kim, K-p, et al.
Publicado: (2011)

Association between cytochrome CYP17A1, CYP3A4, and CYP3A43 polymorphisms and prostate cancer risk and aggressiveness in a Korean study population
por: Han, Jun Hyun, et al.
Publicado: (2015)

Deletions of 9p21 and TP53 in bladder cancer.
por: Park, W. S., et al.
Publicado: (1996)

Profiling of CYP4Z1 and CYP1B1 expression in bladder cancers
por: Al-saraireh, Yousef M., et al.
Publicado: (2021)

CYP2A6 and ERCC1 polymorphisms correlate with efficacy of S-1 plus cisplatin in metastatic gastric cancer patients
por: Park, S R, et al.
Publicado: (2011)

Dietary Flavonoids, CYP1A1 Genetic Variants, and the Risk of Colorectal Cancer in a Korean population
por: Cho, Young Ae, et al.
Publicado: (2017)

Screening of Human CYP1A2 and CYP3A4 Inhibitors from Seaweed In Silico and In Vitro
por: Yim, Sung-Kun, et al.
Publicado: (2020)

Association of CYP1A1 and microsomal epoxide hydrolase polymorphisms with lung squamous cell carcinoma
por: Lin, P, et al.
Publicado: (2000)

Genetic Analyses of the Chimeric CYP11B1/CYP11B2 Gene in a Korean Family with Glucocorticoid-Remediable Aldosteronism
por: Lee, Ihn Suk, et al.
Publicado: (2010)

Analysis of the Risk Factors for Overactive Bladder on the Basis of a Survey in the Community
por: Jo, Jung Ki, et al.
Publicado: (2012)

Expression of CYP2A6, CYP2D6 and CYP4A11 Polymorphisms in COS7 Mammalian Cell Line
por: Lee, Hye Ja, et al.
Publicado: (2011)

CYP1A1 gene polymorphisms as a risk factor for pterygium
por: Young, Chi-Hsien, et al.
Publicado: (2010)

Primary choriocarcinoma of the urinary bladder--a case report.
por: Cho, J. H., et al.
Publicado: (1992)

Screening of Genetic Polymorphisms of CYP3A4 and CYP3A5 Genes
por: Lee, Jin Sol, et al.
Publicado: (2013)

Single monosomy as a relatively better survival factor in acute myeloid leukemia patients with monosomal karyotype
por: Jang, J E, et al.
Publicado: (2015)

Characterization of Two Self-Sufficient Monooxygenases, CYP102A15 and CYP102A170, as Long-Chain Fatty Acid Hydroxylases
por: Rimal, Hemraj, et al.
Publicado: (2020)

Overexpression of cyclin D1 correlates with early recurrence in superficial bladder cancers.
por: Shin, K. Y., et al.
Publicado: (1997)

Incidence and risk factors of recurrence of overactive bladder symptoms after discontinuation of successful medical treatment
por: Kim, Aram, et al.
Publicado: (2017)

Association of CYP26C1 Promoter Hypomethylation with Small Vessel Occlusion in Korean Subjects
por: Lee, Eun-Ji, et al.
Publicado: (2021)

A Study on CYP2C19 and CYP2D6 Polymorphic Effects on Pharmacokinetics and Pharmacodynamics of Amitriptyline in Healthy Koreans
por: Ryu, S, et al.
Publicado: (2017)

Expression Profile of CYP1A1 and CYP1B1 Enzymes in Colon and Bladder Tumors
por: Androutsopoulos, Vasilis P., et al.
Publicado: (2013)

Strong and Selective Inhibitory Effects of the Biflavonoid Selamariscina A against CYP2C8 and CYP2C9 Enzyme Activities in Human Liver Microsomes
por: Park, So-Young, et al.
Publicado: (2020)

Modifiable risk factors for the prevention of bladder cancer: a systematic review of meta-analyses
por: Al-Zalabani, Abdulmohsen H., et al.
Publicado: (2016)

Colorectal adenocarcinoma as a second malignant neoplasm following rhabdomyosarcoma of the urinary bladder: a case report.
por: Park, S. S., et al.
Publicado: (2000)

Analysis of risk factors for post-bacillus Calmette–Guerin-induced prostatitis in patients with non-muscle invasive bladder cancer
por: Kim, Tae Jin, et al.
Publicado: (2020)

Association of CYP gene polymorphisms with breast cancer risk and prognostic factors in the Jordanian population
por: AL-Eitan, Laith N., et al.
Publicado: (2019)

Identification of 74 cytochrome P450 genes and co-localized cytochrome P450 genes of the CYP2K, CYP5A, and CYP46A subfamilies in the mangrove killifish Kryptolebias marmoratus
por: Lee, Bo-Young, et al.
Publicado: (2018)

Association of CYP2E1 gene polymorphisms with bladder cancer risk: A systematic review and meta-analysis
por: Yin, Xiangrui, et al.
Publicado: (2018)

Formation of CYP3A‐specific metabolites of ibrutinib in vitro is correlated with hepatic CYP3A activity and 4β‐hydroxycholesterol/cholesterol ratio
por: Lee, Jonghwa, et al.
Publicado: (2022)

The Expression of Pigment Epithelium-Derived Factor in Bladder Transitional Cell Carcinoma
por: Jang, Tae Jung, et al.
Publicado: (2012)

Genomic Landscape of Experimental Bladder Cancer in Rodents and Its Application to Human Bladder Cancer: Gene Amplification and Potential Overexpression of Cyp2a5/CYP2A6 Are Associated with the Invasive Phenotype
por: Kanemoto, Kazuhiro, et al.
Publicado: (2016)

Effect of CYP3A4*22, CYP3A5*3, and CYP3A combined genotypes on tamoxifen metabolism
por: Sanchez Spitman, A. B., et al.
Publicado: (2017)

Analysis of the immunologic mechanism of intravesical bacillus Calmette-Guerin therapy for superficial bladder tumors: distribution and function of immune cells.
por: Chung, J. Y., et al.
Publicado: (1993)

Controls of Nuclear Factor-Kappa B Signaling Activity by 5’-AMP-Activated Protein Kinase Activation With Examples in Human Bladder Cancer Cells
por: Choi, Bo-Hwa, et al.
Publicado: (2016)

Enhancement of CYP3A4 Activity in Hep G2 Cells by Lentiviral Transfection of Hepatocyte Nuclear Factor-1 Alpha
por: Chiang, Tsai-Shin, et al.
Publicado: (2014)

Feasibility of pharmacy-initiated pharmacogenetic screening for CYP2D6 and CYP2C19
por: Swen, J. J., et al.
Publicado: (2011)

Effect of CYP3A4*22, CYP3A5*3, and CYP3A Combined Genotypes on Cyclosporine, Everolimus, and Tacrolimus Pharmacokinetics in Renal Transplantation
por: Moes, D J A R, et al.
Publicado: (2014)

Enzymatic Characterization and Comparison of Two Steroid Hydroxylases CYP154C3-1 and CYP154C3-2 from Streptomyces Species
por: Subedi, Pradeep, et al.
Publicado: (2021)

Physiologically based pharmacokinetic modelling of atomoxetine with regard to CYP2D6 genotypes
por: Kim, Se-Hyung, et al.
Publicado: (2018)

Short-term Effects of a Systematized Bladder Training Program for Idiopathic Overactive Bladder: A Prospective Study
por: Lee, Hahn-Ey, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_30im27a7ctj8mrra2uobtckick